Global /China /Healthcare /Drug Manufacturers - General /2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd.

2591

• SHEK: 2591 • Delayed

14.00HKD -15%

1.79 USD

As of 16 June 2026, Guangzhou Innogen Pharmaceutical Group Co., Ltd. has a market cap of $955.04M USD, ranking #10983 globally and #3115 in China. It ranks #984 in the Healthcare sector, and #367 in the Drug Manufacturers - General industry.

Global Rank

10983

Country Rank

3115

Sector Rank

984

Industry Rank

367

Key Stats

Market Cap

$955.04MUSD

7.48B HKD

Enterprise Value

$807.46MUSD

6.33B HKD

Revenue (TTM)

$18.68MUSD

146.34M HKD

EBITDA (TTM)

-$47.19MUSD

-369.8M HKD

Net Income (TTM)

-$48.48MUSD

-379.87M HKD

EBITDA Margin

-253%

Profit Margin

-260%

PS Ratio

51.1

PB Ratio

6.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Qinghua Wang open_in_new

Employees

193

Founded

2014

Website

innogenpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-15%	-8.4%	-22%	-46%	-46%	-47%	-89%	-89%	-89%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	2591 ISIN: CNE1000071Q7 Shares Out.: Shares Outstanding: 420.285M¹ Shares Float: 67.437M² TV: TradingView: HKEX: 2591 SA: Stock Analysis: HKG: 2591 YF: Yahoo Finance: 2591.HK GF: Google Finance: HKG: 2591 BA: Barron's: 2591 MS: Morningstar: XHKG: 02591	14.00 HKD	TV: TradingView: HKEX: 2591 SA: Stock Analysis: HKG: 2591 YF: Yahoo Finance: 2591.HK GF: Google Finance: HKG: 2591 BA: Barron's: 2591 MS: Morningstar: XHKG: 02591

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Guangzhou Innogen Pharmaceutical Group Co., Ltd.

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 5K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 80K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 57K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 38K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 34K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 30K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 29K%	20.5	Switzerland

chevron_leftBack